Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 3 (2006), Issue 10 (October)

1. Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.
   Int J Radiat Oncol Biol Phys, 66(3): 699-705. [Abstract] [Full-text]
2. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands.
   Int J Cancer, 119(10): 2372-5. [Abstract] [Full-text]
3. Isolation of Exophiala dermatitidis from endotracheal aspirate of a cancer patient.
   Mycoses, 49(6): 504-9. [Abstract] [Full-text]
4. Inhibition of tumor metastasis in vivo by combination of paclitaxel and hyaluronic acid.
   Cancer Lett, 243(1): 71-9. [Abstract] [Full-text]
5. HPV vaccination with Gardasil: a breakthrough in women's health.
   Expert Opin Biol Ther, 6(11): 1223-7. [Abstract] [Full-text]
6. MRI for pretreatment lymph node staging in uterine cervical cancer.
   AJR Am J Roentgenol, 187(5): W538-43. [Abstract] [Full-text]
7. Atypical immature cervical metaplasia: immunoprofiling and longitudinal outcome.
   Hum Pathol, 37(11): 1473-81. [Abstract] [Full-text]
8. Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa.
   Sex Transm Dis, 33(11): 683-7. [Abstract] [Full-text]
9. Is there a language divide in pap test use?
   Med Care, 44(11): 998-1004. [Abstract] [Full-text]
10. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix.
    Histopathology, 49(5): 493-7. [Abstract] [Full-text]
11. Heritable and environmental components in cervical tumors.
    Int J Cancer, 119(11): 2699-701. [Abstract] [Full-text]
12. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Gynecol Oncol, 103(2): 494-9. [Abstract] [Full-text]
13. Feasibility of extraperitoneal laparoscopic para-aortic and common iliac lymphadenectomy.
    Gynecol Oncol, 103(2): 732-5. [Abstract] [Full-text]
14. Carcinoma in situ cervicis uteri and inheritance--a Danish twin study.
    Gynecol Oncol, 103(2): 688-91. [Abstract] [Full-text]
15. Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma.
    Gynecol Oncol, 103(2): 649-53. [Abstract] [Full-text]
16. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Gynecol Oncol, 103(2): 631-6. [Abstract] [Full-text]
17. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Gynecol Oncol, 103(2): 618-22. [Abstract] [Full-text]
18. Aberrant expression of alpha-dystroglycan in cervical and vulvar cancer.
    Gynecol Oncol, 103(2): 397-404. [Abstract] [Full-text]
19. Cystoscopic temporary ureteral catheterization during radical vaginal and abdominal trachelectomy.
    Gynecol Oncol, 103(2): 729-31. [Abstract] [Full-text]
20. Delivery outcome after cold-knife conization of the uterine cervix.
    Gynecol Oncol, 103(2): 604-7. [Abstract] [Full-text]
21. Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy.
    Gynecol Oncol, 103(2): 547-53. [Abstract] [Full-text]
22. Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study.
    Gynecol Oncol, 103(2): 541-6. [Abstract] [Full-text]
23. The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer.
    Gynecol Oncol, 103(2): 431-4. [Abstract] [Full-text]
24. Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer.
    Gynecol Oncol, 103(2): 506-11. [Abstract] [Full-text]
25. Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Gynecol Oncol, 103(2): 500-5. [Abstract] [Full-text]
26. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
    Gynecol Oncol, 103(2): 435-8. [Abstract] [Full-text]
27. Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
    Gynecol Oncol, 103(2): 489-93. [Abstract] [Full-text]
28. Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data.
    Gynecol Oncol, 103(2): 458-62. [Abstract] [Full-text]
29. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.
    BMC Genomics, 7: 268. [Abstract] [Full-text]
30. Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate.
    J Clin Pathol, 59(11): 1218-20. [Abstract] [Full-text]
31. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.
    Am J Obstet Gynecol, 195(5): 1260-5. [Abstract] [Full-text]
32. Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population.
    J Med Virol, 78(12): 1663-72. [Abstract] [Full-text]

© 2004-2010 Cervical Cancer Research Today. All Rights Reserved.